The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products. It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.
Sofia, Bulgaria, June 11, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 10, 2025 the Company sold 21 413 (twenty-one thousand four hundred thirteen) repurchased own shares representing 0.01% of the share capital of the Company, at a total value of BGN 138 406.16 on the Bulgarian Stock Exchange, the average price per share was BGN 6.46.
Sofia, Bulgaria, June 10, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 9, 2025 the Company sold 260 193 (two hundred sixty thousand one hundred ninety-three) repurchased own shares representing 0.14% of the share capital of the Company, at a total value of BGN 1 678 700.92 on the Bulgarian Stock Exchange, the average price per share was BGN 6.45.
Sofia, Bulgaria, June 9, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 6, 2025 the Company sold 3 310 (three thousand three hundred and ten) repurchased own shares representing 0.002% of the share capital of the Company, at a total value of BGN 21 581.80 on the Bulgarian Stock Exchange, the average price per share was BGN 6.52.
